Synthetic biology applications are being developed for the design of modulated living systems. These can be specialised cells for biosensing, or highly artificial biosyntheses for high-yield production of xenobiologics, biopharmaceutical compounds, fine chemicals for use in vivo or in vitro, or biofuels.
Over the past few years, in a highly active technology-driven period, synthetic biology has been shaped by a small community discussing the potential of new concepts in molecular design adapted from ideas that were first developed in the fields of electronic engineering and IT.
It became clear that the new technologies based on synthetic genes, standardisation of functional molecular parts, synthesis of DNA (the information carrier) and software developed for ‘artificial genetic devices and systems’ had the potential to revolutionise the development of many new applications in bioproduction for many different markets.
Due to this potential for a new bio-based industry, carbon dioxide neutral technologies based on synthetic biology can be the key problem solvers and key drivers in the development of new applications in a clean bioindustry. However in addition, the impact of synthetic biology on the production of biopharmaceuticals and in personalised medicine is also one of the key drivers in the development of new technologies, one such example being the development of arthimisinine by US biotechnology company Amyris.
The Synthetic Biology in Pharma Conference organised jointly by avakado conferences and www.synthetic-biology.info is the first conference designed to bring together pharmaceutical industry experts developing products for different disease indications and leading synthetic biology pioneers in order to create a forum for interchange to identify future high-potential, high-value projects in the pharmaceutical product pipeline.
The conference also covers applications of synthetic biology in medical development, including in drug delivery systems, recombinant antibodies and medical applications based on synthetic biology approaches.
The Synthetic Biology in Pharma conference therefore marks the starting point of a market-driven period for synthetic biology in pharmaceutical and medical supply applications, with the intention of establishing long-term relationships in these areas for all conference participants. To see the conference programme and to register click here
For further information about the important emerging science of synthetic biology
visit: www.synthetic-biology.info
